Observational studyJournal of diabetes investigation2021

Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus treated in real-world clinical practice: Results of a 36-month post-marketing surveillance study (J-STEP/LT).

Kazunori Utsunomiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.